Lina F Chalak1, Pablo J Sánchez2, Beverley Adams-Huet3, Abbot R Laptook4, Roy J Heyne2, Charles R Rosenfeld2. 1. Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: lina.chalak@utsouthwestern.edu. 2. Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX. 3. Department of Clinical Sciences and Statistics, University of Texas Southwestern Medical Center, Dallas, TX. 4. Department of Pediatrics, Brown University, Women & Infants Hospital of Rhode Island, Providence, RI.
Abstract
OBJECTIVE: To evaluate serum neuronal and inflammatory biomarkers to determine whether measurements of umbilical cords at birth can stratify severity of hypoxic-ischemic encephalopathy (HIE), whether serial measurements differ with hypothermia-rewarming, and whether biomarkers correlate with neurological outcomes. STUDY DESIGN: This is a prospective cohort of inborn term newborns with varying degrees of HIE by neurological assessment. Neuronal glial fibrillary acidic protein (GFAP), ubiquitin carboxyl-terminal hydrolase L1, and inflammatory cytokines were measured in serum from umbilical artery at 6-24, 48, 72, and 78 hours of age. Neurodevelopmental outcomes (Bayley Scales of Infant and Toddler Development-III scales) were performed at 15-18 months. RESULTS: Twenty neonates had moderate (n = 17) or severe (n = 3) HIE and received hypothermia; 7 had mild HIE and were not cooled. At birth, serum GFAP and ubiquitin carboxyl-terminal hydrolase L1 increased with the severity of HIE (P < .001), and serial GFAP remained elevated in neonates with moderate to severe HIE. Interleukin (IL)-6, IL-8, and vascular endothelial growth factor were greater at 6-24 hours in moderate to severe vs mild HIE (P < .05). The serial values were unaffected by hypothermia-rewarming. Elevated GFAP, IL-1, IL-6, IL-8, tumor necrosis factor, interferon, and vascular endothelial growth factor at 6-24 hours were associated with abnormal neurological outcomes. CONCLUSIONS: The severity of the hypoxic-ischemic injury can be stratified at birth because elevated neuronal biomarkers in cord serum correlated with severity of HIE and outcomes.
OBJECTIVE: To evaluate serum neuronal and inflammatory biomarkers to determine whether measurements of umbilical cords at birth can stratify severity of hypoxic-ischemicencephalopathy (HIE), whether serial measurements differ with hypothermia-rewarming, and whether biomarkers correlate with neurological outcomes. STUDY DESIGN: This is a prospective cohort of inborn term newborns with varying degrees of HIE by neurological assessment. Neuronal glial fibrillary acidic protein (GFAP), ubiquitin carboxyl-terminal hydrolase L1, and inflammatory cytokines were measured in serum from umbilical artery at 6-24, 48, 72, and 78 hours of age. Neurodevelopmental outcomes (Bayley Scales of Infant and Toddler Development-III scales) were performed at 15-18 months. RESULTS: Twenty neonates had moderate (n = 17) or severe (n = 3) HIE and received hypothermia; 7 had mild HIE and were not cooled. At birth, serum GFAP and ubiquitin carboxyl-terminal hydrolase L1 increased with the severity of HIE (P < .001), and serial GFAP remained elevated in neonates with moderate to severe HIE. Interleukin (IL)-6, IL-8, and vascular endothelial growth factor were greater at 6-24 hours in moderate to severe vs mild HIE (P < .05). The serial values were unaffected by hypothermia-rewarming. Elevated GFAP, IL-1, IL-6, IL-8, tumornecrosis factor, interferon, and vascular endothelial growth factor at 6-24 hours were associated with abnormal neurological outcomes. CONCLUSIONS: The severity of the hypoxic-ischemic injury can be stratified at birth because elevated neuronal biomarkers in cord serum correlated with severity of HIE and outcomes.
Authors: Douglas D Fraser; Taylor E Close; Keeley L Rose; Roxanne Ward; Martin Mehl; Catherine Farrell; Jacques Lacroix; David Creery; Murray Kesselman; Danica Stanimirovic; James S Hutchison Journal: Pediatr Crit Care Med Date: 2011-05 Impact factor: 3.624
Authors: Stephen B Lewis; Regina Wolper; Yueh-Yun Chi; Lynn Miralia; Yong Wang; Cui Yang; Gerry Shaw Journal: J Neurosci Res Date: 2010-05-15 Impact factor: 4.164
Authors: Seetha Shankaran; Patrick D Barnes; Susan R Hintz; Abbott R Laptook; Kristin M Zaterka-Baxter; Scott A McDonald; Richard A Ehrenkranz; Michele C Walsh; Jon E Tyson; Edward F Donovan; Ronald N Goldberg; Rebecca Bara; Abhik Das; Neil N Finer; Pablo J Sanchez; Brenda B Poindexter; Krisa P Van Meurs; Waldemar A Carlo; Barbara J Stoll; Shahnaz Duara; Ronnie Guillet; Rosemary D Higgins Journal: Arch Dis Child Fetal Neonatal Ed Date: 2012-11 Impact factor: 5.747
Authors: Rosemary D Higgins; Tonse N K Raju; Jeffrey Perlman; Denis Victor Azzopardi; Lillian R Blackmon; Reese H Clark; A David Edwards; Donna M Ferriero; Peter D Gluckman; Alistair J Gunn; Susan E Jacobs; Dorothea Jenkins Eicher; Alan H Jobe; Abbot R Laptook; Michael H LeBlanc; Charles Palmer; Seetha Shankaran; Roger F Soll; Ann R Stark; Marianne Thoresen; John Wyatt Journal: J Pediatr Date: 2006-02 Impact factor: 4.406
Authors: Nienke Wagenaar; Caroline G M de Theije; Linda S de Vries; Floris Groenendaal; Manon J N L Benders; Cora H A Nijboer Journal: Pediatr Res Date: 2017-11-01 Impact factor: 3.756
Authors: Lauren E Kelly; Kimberly Caswell; Mary A Short; Prabhu S Parimi; Martin Offringa; Thomas Diacovo Journal: Pediatr Res Date: 2017-09-27 Impact factor: 3.756
Authors: Ericka L Fink; Rachel P Berger; Robert S B Clark; R Scott Watson; Derek C Angus; Ashok Panigrahy; Rudolph Richichi; Clifton W Callaway; Michael J Bell; Stefania Mondello; Ronald L Hayes; Patrick M Kochanek Journal: Resuscitation Date: 2016-02-06 Impact factor: 5.262